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Introduction
We read with great interest the recent article by Saad et al.
[1]. We fully agree with the authors that balloon-occluded
retrograde transvenous obliteration (BRTO) is a valuable
treatment that can be used as an alternative to transjugular
intrahepatic portosystemic shunt (TIPS). BRTO is also an
excellent treatment option in patients for whom TIPS
would not be beneficial. Gastric varices most commonly
occur in patients with portal hypertension due to cirrhosis.
Yet gastric varices may also develop in patients without
underlying liver cirrhosis, and TIPS may not be beneficial
or possible in these patients. BRTO is preferred over TIPS
in such cases. We present a case of BRTO in a patient with
active hemorrhage from gastric varices that were due to
post pancreatitis splenic vein occlusion.
Case Report
Approval by the institutional review board and informed
consent are not required for anonymized case reports in our
institution. A 62-year-old man with chronic pancreatitis
was admitted to the gastroenterology department of another
institution with severe hematemesis and melena. Medical
history included diabetes mellitus type 2 and hypertension.
The patient was admitted to the intensive care unit and
subsequently intubated. Hemoglobin had dropped to
4.1 mmol/L (previously known normal value was
8.1 mmol/L), and three units of packed red blood cells and
three units of fresh frozen plasma were administered.
During the first few days, repeated gastroscopy per-
formed in the referring hospital showed extensive clot for-
mation in the gastric fundus without visualization of a
possible active bleeding site. One day before transfer to our
institution, gastroscopy revealed active hemorrhage from
gastric varices, but Histoacryl injection was not considered
to be feasible as a result of poor visualization of the bleeding
focus. To control the bleeding, a Sengstaken–Blakemore
tube was placed after each gastroscopy. A two-phase
abdominal computed tomography (CT) with intravenous
contrast was performed and revealed a gastrorenal shunt and
active bleeding of gastric varices, signs of chronic pancre-
atitis, and splenic vein occlusion (Figs. 1 and 2). With the
Sengstaken-Blakemore tube in situ, the patient was trans-
ferred to our hospital for further treatment.
He was hemodynamically stable on arrival at our hospital.
Baseline laboratory values were as follows: ammonia 71 g/L,
alkaline phosphatase 98 U/L, gamma glutamyl transferase 90
U/L, aspartate transaminase 22 U/L, alanine transaminase 22
U/L, lactate dehydrogenase 154 U/L, amylase 30 U/L,
hemoglobin 6.2 mmol/L, thrombocytes 83 9 109/L, inter-
national normalized ratio 1.2, and activated partial throm-
boplastin time 32.8 s. It was decided to perform transjugular
measurements of the hepatic vein pressure gradient and
proceed with BRTO in the absence of portal hypertension.
The BRTO procedure was performed under general
anesthesia. An 8F Berenstein occlusion balloon (Boston
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Scientific, Natick, MA, USA) was introduced through a 8F
Brite-Tip vascular sheath (Cordis, Miami Lakes, FL, USA)
placed in the right jugular vein and used to measure the
hepatic vein pressure gradient. The hepatic vein pressure
gradient was 3 mm Hg, and right-sided portal hypertension
was thus ruled out.
Under ultrasonographic guidance, the right common
femoral vein was punctured and a 9F Brite-Tip vascular
sheath (Cordis) was introduced. The left renal vein and
gastrorenal shunt were selectively catheterized using a 4F
multipurpose catheter (Cordis) and 0.03500 stiff Terumo
guide wire (Terumo, Tokyo, Japan). An 8F Berenstein
occlusion balloon (Boston Scientific) was then inserted
over the guide wire and into the gastrorenal shunt. Balloon-
occluded venography revealed a large tortuous varix at the
location of the lesser curvature of the stomach (Fig. 3). The
left phrenic vein was catheterized using a 2.7F Progreat
microcatheter (Terumo, Tokyo, Japan) and selectively
coiled with two diamond-shaped 3 mm microcoils (Boston
Scientific). A mixture of gelfoam, 6 mL of Ultravist 300,
2 mL of lipiodol, and 6 mL of aethoxysclerol 1 % (10 mg/
mL) was injected through the occlusion balloon (Fig. 3).
The occlusion balloon remained inflated in the gastrorenal
shunt for 12 h, after which it was removed under fluoro-
scopic guidance. No complications occurred during the
procedure. A three-phase CT performed 2 days after the
procedure showed successful occlusion of the embolized
gastric varices and no signs of bleeding (Fig. 3). The
patient was discharged from the hospital 1 week later
without any further rebleeding and a hemoglobin of
7 mmol/L before discharge.
Discussion
Gastric varices most commonly occur in patients with
portal hypertension due to cirrhosis. The patient we
describe in this case report, however, had gastric varices
Fig. 1 Axial CT images in arterial phase (A) and portal venous phase (B) show gastric varices (arrows) with active bleeding (arrowheads) and
blood-filled stomach (stars). Note the more prominent active bleed on the portal venous image (B)
Fig. 2 Coronal CT images in portal venous phase show the gastrorenal shunt (arrow, A) and gastric varices (arrowhead, A). Pancreatic
calcifications in the setting of chronic pancreatitis are seen in the pancreatic body and head (arrows, B)
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due to postpancreatitis splenic vein thrombosis, causing
localized portal hypertension. In a study by Sarin et al. [2]
including 568 patients with portal hypertension, liver cir-
rhosis was the cause of portal hypertension in 53.0 % of
patients. Other causes of portal hypertension were non-
cirrhotic portal fibrosis (20.2 % of patients), extrahepatic
portal vein obstruction (20.6 %), and hepatic venous out-
flow obstruction (3.5 %). Of all patients in the study, 20 %
had gastric varices. The incidence of gastric varices in the
patients with extrahepatic portal vein obstruction was
higher (38.5 %) compared to patients with noncirrhotic
portal fibrosis (30.4 %), cirrhosis (21.6 %), and hepatic
venous outflow obstruction (5.7 %). A systematic review
and meta-analysis by Butler et al. [3] showed that splenic
vein thrombosis is frequently observed in the setting of
pancreatitis (acute and chronic) and may lead to esophag-
ogastric varices in many cases. Gastric varices are observed
in 77.3 % of patients with pancreatitis-induced splenic vein
thrombosis, and the associated GI bleeding rate in patients
with this thrombosis is as high as 12.3 % [3]. Bleeding
from gastric varices in patients with portal hypertension is
less common than from esophageal varices but is associ-
ated with higher mortality rates [2]. Moreover, gastric
varices seem to bleed at lower portal pressures than
esophageal varices [4]. As mentioned by Saad et al. [1],
endoscopic treatment of bleeding gastric varices is less
effective compared to esophageal varices.
The first-line treatment for bleeding gastric varices is
endoscopic injection sclerotherapy. When an endoscopic
approach fails, the choices consist of TIPS or BRTO. In
Western countries, TIPS is the preferred option because
this deals with the underlying problem of portal hyper-
tension [1]. However, in patients with gastric varices
without right-sided portal hypertension, TIPS may not be
effective in achieving decompression of the varices [5]. In
such patients with left-sided portal hypertension, BRTO is
the preferred therapeutic option, as it was in the case
described. As highlighted by Saad et al. [1], a gastrorenal
shunt may be absent in 15–16 % of patients with gastric
varices. BRTO may only be possible in such cases using
other collateral portosystemic pathways. Yet performing
BRTO via such unconventional pathways is difficult and
requires extensive BRTO experience. Alternatively, if
endoscopic Histoacryl injection is not feasible, percutane-
ous transhepatic obliteration may be used to treat gastric
varices in the absence of a gastrorenal shunt. This approach
is technically less challenging and can also be attempted
after unsuccessful BRTO [1, 6].
Both BRTO and TIPS are effective in treating gastric
varices caused by portal hypertension. When gastric
Fig. 3 Angiography before (arrow, A) and after (arrows, B) embo-
lization of gastric varices and gastrorenal shunt. Left phrenic vein
(black arrowhead, A) was embolized with coils (arrowhead, B).
Sengstaken-Blakemore tube was placed to control bleeding (white
arrowheads, A). Corresponding coronal CT image 2 days after
embolization indicates successful embolization of gastric varices
and gastrorenal shunt (C)
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varices develop in the absence of right-sided portal
hypertension—for example, as result of splenic vein
thrombosis—TIPS may not be effective. Therefore, inter-
ventional radiologists should be familiar with and capable
of performing BRTO.
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